Risk of lymphoma in patients with inflammatory bowel disease
- PMID: 22347833
- PMCID: PMC3277199
Risk of lymphoma in patients with inflammatory bowel disease
Similar articles
-
Inflammatory bowel disease is not associated with an increased risk of lymphoma.Gastroenterology. 2001 Nov;121(5):1080-7. doi: 10.1053/gast.2001.28703. Gastroenterology. 2001. PMID: 11677199
-
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis.J Crohns Colitis. 2018 Aug 29;12(9):1042-1052. doi: 10.1093/ecco-jcc/jjy065. J Crohns Colitis. 2018. PMID: 29762681
-
Risk of lymphoma in inflammatory bowel disease.Am J Gastroenterol. 2000 Sep;95(9):2308-12. doi: 10.1111/j.1572-0241.2000.02316.x. Am J Gastroenterol. 2000. PMID: 11007233
-
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.Aliment Pharmacol Ther. 2001 Aug;15(8):1101-8. doi: 10.1046/j.1365-2036.2001.01023.x. Aliment Pharmacol Ther. 2001. PMID: 11472312 Review.
-
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.Gastroenterology. 2002 Jan;122(1):72-7. doi: 10.1053/gast.2002.30328. Gastroenterology. 2002. PMID: 11781282
Cited by
-
Epstein-Barr Virus: Diseases Linked to Infection and Transformation.Front Microbiol. 2016 Oct 25;7:1602. doi: 10.3389/fmicb.2016.01602. eCollection 2016. Front Microbiol. 2016. PMID: 27826287 Free PMC article. Review.
-
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn's colitis.Hum Pathol. 2016 Nov;57:45-50. doi: 10.1016/j.humpath.2016.06.021. Epub 2016 Jul 8. Hum Pathol. 2016. PMID: 27402301 Free PMC article.
References
-
- Bewtra M, Lewis JD. Safety profile of IBD: lymphoma risks. Gastroenterol Clin North Am. 2009;38:669–689. - PubMed
-
- Beaugerie L, Brousse N, Bouvier AM, et al. CESAME Study Group. Lympho-proliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–1625. - PubMed
-
- Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011;106:2146–2153. - PubMed
-
- Van Assche G, Lewis JD, Lichtenstein GR, et al. The London position statement of the World Congress of Gastroenterology on biological therapy for IBD with the European Crohn舗s and Colitis Organisation: safety. Am J Gastroenterol. 2011;106:1594–1602. quiz 1593, 1603. - PubMed
LinkOut - more resources
Full Text Sources